Efficacy and safety of XELOX combined with anlotinib and penpulimab vs XELOX as adjuvant therapy in ctDNA-positive gastric and esophagogastric junction adenocarcinoma: A protocol for a randomized, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback